Samkeppniseftirlitið tilkynnti Símanum hf. í dag að stofnunin hefði lokið rannsókn á kaupum Símans hf. á Greiðslumiðlun Íslands ehf. sem Síminn hf. tilkynnti opinberlega um þann 23. október sl. Með hliðsjón af fyrirliggjandi gögnum taldi Samkeppniseftirlitið ekki tilefni til íhlutunar vegna kaupanna og hefur þar með lokið meðferð málsins.
ZURICH, 15 août 2025 (GLOBE NEWSWIRE) -- L’EAACI a lancé sa Antibiotic Allergy Awareness Campaign (Campagne de sensibilisation aux allergies aux antibiotiques) à l’occasion de son Congrès 2025 à Glasgow. Cette initiative marque le début d’un effort mondial visant à lutter contre les erreurs d’étiquetage et son lien avec la résistance aux antimicrobiens (RAM).
Charity auction raises $250,000 for Children's Miracle Network Hospitals
NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Children's Miracle Network Hospitals (CMN Hospitals) announced that...
Óskar Hauksson, fjármálastjóri Símans, hefur ákveðið að láta af störfum hjá félaginu. Óskar hefur starfað hjá Símanum frá árinu 2005, en sem fjármálastjóri frá 2011. Hann mun láta af störfum þann 1. október næstkomandi og verður forstjóra innan handar þar til ráðið hefur verið í starfið.
ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Pearson is proud to recognize the winners of the 2025 Microsoft Office Specialist (MOS) World Championship, announced by Certiport, a Pearson VUE business, and the leading provider of performance-based IT certification exams that accelerate academic and career opportunities for learners.
LOS ANGELES, July 29, 2025 /PRNewswire/ -- OUAI, the community-loved haircare brand founded by renowned celebrity hairstylist Jen Atkin, is officially launching in SalonCentric...
Key Takeaways
At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of...
LUND, Sweden, July 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION